Akyildiz, A. Et Al. 2024. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).. Special Clinical Science Symposia , (ELECTR NETWORK).

Akyildiz, A., Guven, D. C., Koksal, B., Karaoglan, B. B., Salim, D. K., Sutcuoglu, O., ... Erciyestepe, M.(2024). Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG). . Special Clinical Science Symposia, ELECTR NETWORK

Akyildiz, ARİF Et Al. "Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).," Special Clinical Science Symposia, ELECTR NETWORK, 2024

Akyildiz, ARİF Et Al. "Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).." Special Clinical Science Symposia , ELECTR NETWORK, 2024

Akyildiz, A. Et Al. (2024) . "Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).." Special Clinical Science Symposia , ELECTR NETWORK.

@conferencepaper{conferencepaper, author={ARİF AKYILDIZ Et Al. }, title={Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).}, congress name={Special Clinical Science Symposia}, city={}, country={ELECTR NETWORK}, year={2024}}